STOCK TITAN

[SCHEDULE 13D] Alkami Technology, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D
Rhea-AI Filing Summary

General Atlantic and affiliated funds filed a Schedule 13D reporting shared beneficial ownership of 12,033,436 shares of Alkami Technology, Inc. common stock, representing 11.6% of the class based on 104,083,138 shares outstanding as of June 30, 2025. This Schedule 13D amends and supersedes a previously filed Schedule 13G/A.

The filing states the shares were acquired for investment purposes. The Reporting Persons may engage with shareholders, management or the board and may buy, sell or otherwise change their position over time. Purchases during the 60-day period before August 20, 2025 are reported in an attached Annex A. The group entered a Joint Filing Agreement and discloses shared voting and dispositive power over the reported shares.

General Atlantic e fondi correlati hanno depositato un Schedule 13D dichiarando la proprietà comune di 12.033.436 azioni ordinarie di Alkami Technology, Inc., pari al 11,6% della classe sulla base di 104.083.138 azioni in circolazione al 30 giugno 2025. Questo Schedule 13D modifica e sostituisce un precedente Schedule 13G/A.

La comunicazione indica che le azioni sono state acquisite a fini di investimento. Le Persone Dichiaranti potrebbero interagire con gli azionisti, la direzione o il consiglio e potrebbero comprare, vendere o altrimenti modificare la loro posizione nel tempo. Gli acquisti effettuati nei 60 giorni precedenti il 20 agosto 2025 sono riportati nell'Allegato A. Il gruppo ha stipulato un accordo di deposito congiunto e dichiara poteri condivisi di voto e dispositivi sulle azioni riportate.

General Atlantic y fondos afiliados presentaron un Schedule 13D informando la propiedad beneficiosa compartida de 12.033.436 acciones ordinarias de Alkami Technology, Inc., que representan el 11,6% de la clase, sobre la base de 104.083.138 acciones en circulación al 30 de junio de 2025. Este Schedule 13D enmienda y reemplaza un Schedule 13G/A presentado anteriormente.

La presentación señala que las acciones se adquirieron con fines de inversión. Las Personas Informantes pueden relacionarse con accionistas, la dirección o el consejo y pueden comprar, vender o de otro modo cambiar su posición con el tiempo. Las compras realizadas en los 60 días anteriores al 20 de agosto de 2025 se informan en un Anexo A adjunto. El grupo celebró un Acuerdo de Presentación Conjunta y declara tener poderes compartidos de voto y disposición sobre las acciones informadas.

General Atlantic 및 계열 펀드는 Schedule 13D를 제출하여 Alkami Technology, Inc. 보통주 12,033,436주를 공동으로 보유하고 있음을 보고했으며, 이는 2025년 6월 30일 기준 발행주식수 104,083,138주를 기준으로 클래스의 11.6%에 해당합니다. 본 Schedule 13D는 이전에 제출된 Schedule 13G/A를 수정·대체합니다.

신고서에 따르면 해당 주식은 투자 목적으로 취득되었다고 합니다. 보고자들은 주주, 경영진 또는 이사회와 교섭할 수 있으며 시간이 지나면서 매수·매도하거나 보유지분을 변경할 수 있습니다. 2025년 8월 20일 이전 60일 동안의 매수 내역은 첨부된 부록 A에 기재되어 있습니다. 이 그룹은 공동 제출 계약을 체결했으며 보고된 주식에 대해 공동의 의결권 및 처분권을 보유하고 있음을 공시합니다.

General Atlantic et des fonds affiliés ont déposé un Schedule 13D déclarant la propriété bénéficiaire partagée de 12 033 436 actions ordinaires d'Alkami Technology, Inc., représentant 11,6% de la catégorie sur la base de 104 083 138 actions en circulation au 30 juin 2025. Ce Schedule 13D modifie et remplace un Schedule 13G/A précédemment déposé.

Le dépôt indique que les actions ont été acquises à des fins d'investissement. Les personnes déclarante peuvent dialoguer avec les actionnaires, la direction ou le conseil et peuvent acheter, vendre ou autrement modifier leur position au fil du temps. Les achats effectués durant la période de 60 jours précédant le 20 août 2025 sont signalés dans une annexe A jointe. Le groupe a conclu un accord de dépôt conjoint et déclare détenir des pouvoirs de vote et de disposition partagés sur les actions déclarées.

General Atlantic und angeschlossene Fonds haben ein Schedule 13D eingereicht und damit gemeinsames wirtschaftliches Eigentum an 12.033.436 Stammaktien von Alkami Technology, Inc. gemeldet, was auf Basis von 104.083.138 ausstehenden Aktien zum 30. Juni 2025 11,6% der Klasse entspricht. Dieses Schedule 13D ändert und ersetzt ein zuvor eingereichtes Schedule 13G/A.

Die Meldung gibt an, dass die Aktien zu Investitionszwecken erworben wurden. Die meldenden Personen können mit Aktionären, dem Management oder dem Vorstand in Kontakt treten und ihre Position im Laufe der Zeit durch Käufe, Verkäufe oder sonstige Änderungen anpassen. Käufe im 60-Tage-Zeitraum vor dem 20. August 2025 sind in einem beigefügten Anhang A aufgeführt. Die Gruppe hat eine gemeinsame Einreichungsvereinbarung getroffen und gibt gemeinsame Stimm- und Verfügungsrechte über die gemeldeten Aktien an.

Positive
  • Reporting Persons disclose a material 11.6% beneficial ownership (12,033,436 shares), providing transparency to investors
  • The filing amends a prior Schedule 13G/A to a Schedule 13D, increasing regulatory disclosure and signaling readiness to engage with the company
  • Purchases were funded by specified GA Funds and Sponsor Coinvestment Funds, and recent transactions during the 60-day period are disclosed in Annex A
Negative
  • The Reporting Persons reserve the right to buy or sell and to engage with management, which could introduce shareholder activism or strategic uncertainty
  • Shared voting and dispositive power across multiple affiliated entities may complicate clarity on who will drive any future decisions regarding the stake

Insights

TL;DR General Atlantic's disclosed 11.6% stake is a substantial passive-to-active investment signal with potential governance influence.

The Schedule 13D shows a coordinated ownership of 12,033,436 shares, equating to 11.6% of Alkami's outstanding common stock. Filing on a Schedule 13D (rather than remaining on a 13G) indicates increased disclosure obligations and signals willingness to engage with the company. The group discloses shared voting and dispositive power and reserves the right to communicate with management, the board and other shareholders. Annex A (referenced) records recent purchases within the 60-day lookback, indicating the position was accumulated via open-market and block trades using fund capital. This level of ownership is material relative to a single shareholder and may prompt investor interest and potential board or strategic discussions.

TL;DR A group filing of this size creates practical leverage to request meetings or offer governance feedback, though no formal proposals are stated.

The Reporting Persons explicitly state they may communicate with management and the board and may suggest changes to operations, strategy or board composition, but they also state no present plans to take the specific actions listed in Item 4 clauses (a)-(j). The Joint Filing Agreement and shared voting/dispositive power disclosures clarify coordination among fund vehicles controlled by General Atlantic and its Partnership Committee. That coordination, combined with an >10% stake, is material from a governance standpoint because it provides the Reporting Persons standing to seek engagement without having declared definitive proposals or transactions.

General Atlantic e fondi correlati hanno depositato un Schedule 13D dichiarando la proprietà comune di 12.033.436 azioni ordinarie di Alkami Technology, Inc., pari al 11,6% della classe sulla base di 104.083.138 azioni in circolazione al 30 giugno 2025. Questo Schedule 13D modifica e sostituisce un precedente Schedule 13G/A.

La comunicazione indica che le azioni sono state acquisite a fini di investimento. Le Persone Dichiaranti potrebbero interagire con gli azionisti, la direzione o il consiglio e potrebbero comprare, vendere o altrimenti modificare la loro posizione nel tempo. Gli acquisti effettuati nei 60 giorni precedenti il 20 agosto 2025 sono riportati nell'Allegato A. Il gruppo ha stipulato un accordo di deposito congiunto e dichiara poteri condivisi di voto e dispositivi sulle azioni riportate.

General Atlantic y fondos afiliados presentaron un Schedule 13D informando la propiedad beneficiosa compartida de 12.033.436 acciones ordinarias de Alkami Technology, Inc., que representan el 11,6% de la clase, sobre la base de 104.083.138 acciones en circulación al 30 de junio de 2025. Este Schedule 13D enmienda y reemplaza un Schedule 13G/A presentado anteriormente.

La presentación señala que las acciones se adquirieron con fines de inversión. Las Personas Informantes pueden relacionarse con accionistas, la dirección o el consejo y pueden comprar, vender o de otro modo cambiar su posición con el tiempo. Las compras realizadas en los 60 días anteriores al 20 de agosto de 2025 se informan en un Anexo A adjunto. El grupo celebró un Acuerdo de Presentación Conjunta y declara tener poderes compartidos de voto y disposición sobre las acciones informadas.

General Atlantic 및 계열 펀드는 Schedule 13D를 제출하여 Alkami Technology, Inc. 보통주 12,033,436주를 공동으로 보유하고 있음을 보고했으며, 이는 2025년 6월 30일 기준 발행주식수 104,083,138주를 기준으로 클래스의 11.6%에 해당합니다. 본 Schedule 13D는 이전에 제출된 Schedule 13G/A를 수정·대체합니다.

신고서에 따르면 해당 주식은 투자 목적으로 취득되었다고 합니다. 보고자들은 주주, 경영진 또는 이사회와 교섭할 수 있으며 시간이 지나면서 매수·매도하거나 보유지분을 변경할 수 있습니다. 2025년 8월 20일 이전 60일 동안의 매수 내역은 첨부된 부록 A에 기재되어 있습니다. 이 그룹은 공동 제출 계약을 체결했으며 보고된 주식에 대해 공동의 의결권 및 처분권을 보유하고 있음을 공시합니다.

General Atlantic et des fonds affiliés ont déposé un Schedule 13D déclarant la propriété bénéficiaire partagée de 12 033 436 actions ordinaires d'Alkami Technology, Inc., représentant 11,6% de la catégorie sur la base de 104 083 138 actions en circulation au 30 juin 2025. Ce Schedule 13D modifie et remplace un Schedule 13G/A précédemment déposé.

Le dépôt indique que les actions ont été acquises à des fins d'investissement. Les personnes déclarante peuvent dialoguer avec les actionnaires, la direction ou le conseil et peuvent acheter, vendre ou autrement modifier leur position au fil du temps. Les achats effectués durant la période de 60 jours précédant le 20 août 2025 sont signalés dans une annexe A jointe. Le groupe a conclu un accord de dépôt conjoint et déclare détenir des pouvoirs de vote et de disposition partagés sur les actions déclarées.

General Atlantic und angeschlossene Fonds haben ein Schedule 13D eingereicht und damit gemeinsames wirtschaftliches Eigentum an 12.033.436 Stammaktien von Alkami Technology, Inc. gemeldet, was auf Basis von 104.083.138 ausstehenden Aktien zum 30. Juni 2025 11,6% der Klasse entspricht. Dieses Schedule 13D ändert und ersetzt ein zuvor eingereichtes Schedule 13G/A.

Die Meldung gibt an, dass die Aktien zu Investitionszwecken erworben wurden. Die meldenden Personen können mit Aktionären, dem Management oder dem Vorstand in Kontakt treten und ihre Position im Laufe der Zeit durch Käufe, Verkäufe oder sonstige Änderungen anpassen. Käufe im 60-Tage-Zeitraum vor dem 20. August 2025 sind in einem beigefügten Anhang A aufgeführt. Die Gruppe hat eine gemeinsame Einreichungsvereinbarung getroffen und gibt gemeinsame Stimm- und Verfügungsrechte über die gemeldeten Aktien an.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
(1) Includes 34,731 shares and 7,225 restricted stock units held by Raphael Osnoss, who is an employee of General Atlantic Service Company, L.P. ("GASC"), solely for the benefit of GASC, which is controlled by the Partnership Committee (as defined below).


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


General Atlantic, L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director
Date:08/20/2025
General Atlantic (SPV) GP, LLC
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of General Atlantic, L.P., its sole member
Date:08/20/2025
General Atlantic Partners 100, L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of General Atlantic, L.P., the general partner of General Atlantic GenPar, L.P., its general partner
Date:08/20/2025
General Atlantic (AL), L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of General Atlantic, L.P., the sole member of General Atlantic (SPV) GP, LLC, its general partner
Date:08/20/2025
General Atlantic Partners (Bermuda) EU, L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of GAP (Bermuda) GP Ltd, GP of GAP (Bermuda) L.P., GP of General Atlantic GenPar (Bermuda), L.P, its general partner
Date:08/20/2025
General Atlantic Partners (Lux) SCSp
Signature:/s/ Ingrid van der Hoorn
Name/Title:Ingrid van der Hoorn, Manager A of General Atlantic (Lux) S.a r.l., the general partner of General Atlantic GenPar (Lux) SCSp, its general partner
Date:08/20/2025
Signature:/s/ William Blackwell
Name/Title:William Blackwell, Manager B of General Atlantic (Lux) S.a r.l., the general partner of General Atlantic GenPar (Lux) SCSp, its general partner
Date:08/20/2025
General Atlantic GenPar, L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of General Atlantic, L.P., its general partner
Date:08/20/2025
GAP Coinvestments III, LLC
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of General Atlantic, L.P., its managing member
Date:08/20/2025
GAP Coinvestments IV, LLC
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of General Atlantic, L.P., its managing member
Date:08/20/2025
GAP Coinvestments V, LLC
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of General Atlantic, L.P., its managing member
Date:08/20/2025
GAP Coinvestments CDA, L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of General Atlantic, L.P., its general partner
Date:08/20/2025
General Atlantic GenPar (Lux) SCSp
Signature:/s/ Ingrid van der Hoorn
Name/Title:Ingrid van der Hoorn, Manager A of General Atlantic (Lux) S.a r.l., its general partner
Date:08/20/2025
Signature:/s/ William Blackwell
Name/Title:William Blackwell, Manager B of General Atlantic (Lux) S.a r.l., its general partner
Date:08/20/2025
General Atlantic (Lux) S.a r.l.
Signature:/s/ Ingrid van der Hoorn
Name/Title:Ingrid van der Hoorn, Manager A
Date:08/20/2025
Signature:/s/ William Blackwell
Name/Title:William Blackwell, Manager B
Date:08/20/2025
General Atlantic GenPar (Bermuda), L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of GAP (Bermuda) GP Limited, the general partner of GAP (Bermuda) L.P., its general partner
Date:08/20/2025
GAP (Bermuda) L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of GAP (Bermuda) GP Limited, its general partner
Date:08/20/2025
General Atlantic Partners (Bermuda) IV, L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of GAP (Bermuda) GP Limited, the GP of GAP (BERMUDA) L.P., the GP of GENERAL ATLANTIC GENPAR (BERMUDA), L.P., its GP
Date:08/20/2025
General Atlantic (SPV) GP (Bermuda), LLC
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of GAP (BERMUDA) L.P., the general partner of GENERAL ATLANTIC GENPAR (BERMUDA), L.P., its managing member
Date:08/20/2025
General Atlantic Partners (Bermuda) T, L.P.
Signature:/s/ Michael Gosk
Name/Title:Michael Gosk, Managing Director of GENERAL ATLANTIC (SPV) GP (BERMUDA), LLC, its general partner
Date:08/20/2025

FAQ

How many ALKT shares does General Atlantic report owning?

The Reporting Persons disclose beneficial ownership of 12,033,436 shares, equal to 11.6% of common stock based on 104,083,138 shares outstanding as of June 30, 2025.

Did General Atlantic file a Schedule 13D or 13G for ALKT?

They filed a Schedule 13D that amends and supersedes a previously filed Schedule 13G/A.

What is the stated purpose of General Atlantic's ALKT holdings?

The shares were acquired for investment purposes; the Reporting Persons state they may communicate with shareholders, management or the board and may change their position over time.

Does the filing show whether purchases were recent?

Yes. The filing references an Annex A that specifies dates, amounts and weighted average prices of purchases during the 60-day period prior to August 20, 2025.

Do the Reporting Persons control how the shares are voted?

The Reporting Persons report shared voting powershared dispositive power over the 12,033,436 shares.
Alkami Technology, Inc.

NASDAQ:ALKT

ALKT Rankings

ALKT Latest News

ALKT Latest SEC Filings

ALKT Stock Data

2.32B
67.09M
24.84%
86.27%
6.75%
Software - Application
Services-prepackaged Software
Link
United States
PLANO